| Mrs Athena C Fertig, APRN,PMHNP-BC,NP-C | |
|
300 W Broadway Ste 240, Council Bluffs, IA 51503-9028 | |
| (712) 266-3577 | |
| (712) 336-8541 |
| Full Name | Mrs Athena C Fertig |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 14 Years |
| Location | 300 W Broadway Ste 240, Council Bluffs, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093028805 | NPI | - | NPPES |
| 48515 | Other | NE | BCBS NE (PLH) |
| 47279 | Other | NE | BCBS NE |
| 10025024400 | Medicaid | NE | |
| 10025024300 | Medicaid | NE |
| Entity Name | New Century Physicians Of Iowa Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548269301 PECOS PAC ID: 4880587070 Enrollment ID: O20040203000297 |
News Archive
Which medical news stories are physicians reading to stay informed about key developments? MedPage Today publishes the Most Read Stories for the Past Week.
Promedior, Inc., a leader in the development of novel therapeutics for the treatment of fibrotic diseases and tissue remodeling, announced today that the European Commission has granted Orphan Medicinal Product Designation to its lead drug candidate PRM-151 for use in the prevention of scarring post glaucoma filtration surgery.
Ebola virus (EboV) is the cause of sporadic outbreaks of highly fatal infections in Africa that are unpredictable in onset and rapid in progression. There is no effective vaccine or therapy for EboV infection.
Today's headlines include analysis of how this year's health reform debate is shaping other national policy initiatives and the upcoming mid-term elections.
Scripps Research Institute scientists have discovered a basic mechanism that can enable developing cancer cells to sustain abnormal growth. The finding is expected to lead to the targeting of this mechanism with drugs and diagnostic techniques.
› Verified 3 days ago
| Entity Name | Forefront Telecare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174035612 PECOS PAC ID: 9638319114 Enrollment ID: O20190821004732 |
News Archive
Which medical news stories are physicians reading to stay informed about key developments? MedPage Today publishes the Most Read Stories for the Past Week.
Promedior, Inc., a leader in the development of novel therapeutics for the treatment of fibrotic diseases and tissue remodeling, announced today that the European Commission has granted Orphan Medicinal Product Designation to its lead drug candidate PRM-151 for use in the prevention of scarring post glaucoma filtration surgery.
Ebola virus (EboV) is the cause of sporadic outbreaks of highly fatal infections in Africa that are unpredictable in onset and rapid in progression. There is no effective vaccine or therapy for EboV infection.
Today's headlines include analysis of how this year's health reform debate is shaping other national policy initiatives and the upcoming mid-term elections.
Scripps Research Institute scientists have discovered a basic mechanism that can enable developing cancer cells to sustain abnormal growth. The finding is expected to lead to the targeting of this mechanism with drugs and diagnostic techniques.
› Verified 3 days ago
| Entity Name | Athena Integrated Care Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508582289 PECOS PAC ID: 3779950902 Enrollment ID: O20221101001702 |
News Archive
Which medical news stories are physicians reading to stay informed about key developments? MedPage Today publishes the Most Read Stories for the Past Week.
Promedior, Inc., a leader in the development of novel therapeutics for the treatment of fibrotic diseases and tissue remodeling, announced today that the European Commission has granted Orphan Medicinal Product Designation to its lead drug candidate PRM-151 for use in the prevention of scarring post glaucoma filtration surgery.
Ebola virus (EboV) is the cause of sporadic outbreaks of highly fatal infections in Africa that are unpredictable in onset and rapid in progression. There is no effective vaccine or therapy for EboV infection.
Today's headlines include analysis of how this year's health reform debate is shaping other national policy initiatives and the upcoming mid-term elections.
Scripps Research Institute scientists have discovered a basic mechanism that can enable developing cancer cells to sustain abnormal growth. The finding is expected to lead to the targeting of this mechanism with drugs and diagnostic techniques.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Athena C Fertig, APRN,PMHNP-BC,NP-C 300 W Broadway Ste 240, Council Bluffs, IA 51503-9028 Ph: (712) 266-3577 | Mrs Athena C Fertig, APRN,PMHNP-BC,NP-C 300 W Broadway Ste 240, Council Bluffs, IA 51503-9028 Ph: (712) 266-3577 |
News Archive
Which medical news stories are physicians reading to stay informed about key developments? MedPage Today publishes the Most Read Stories for the Past Week.
Promedior, Inc., a leader in the development of novel therapeutics for the treatment of fibrotic diseases and tissue remodeling, announced today that the European Commission has granted Orphan Medicinal Product Designation to its lead drug candidate PRM-151 for use in the prevention of scarring post glaucoma filtration surgery.
Ebola virus (EboV) is the cause of sporadic outbreaks of highly fatal infections in Africa that are unpredictable in onset and rapid in progression. There is no effective vaccine or therapy for EboV infection.
Today's headlines include analysis of how this year's health reform debate is shaping other national policy initiatives and the upcoming mid-term elections.
Scripps Research Institute scientists have discovered a basic mechanism that can enable developing cancer cells to sustain abnormal growth. The finding is expected to lead to the targeting of this mechanism with drugs and diagnostic techniques.
› Verified 3 days ago
Jennifer L Achenbach, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 800 Mercy Dr, Council Bluffs, IA 51503 Phone: 712-325-2484 | |
Mallory Lloyd, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 808 E Pierce St, Council Bluffs, IA 51503 Phone: 402-740-6503 | |
Michelle Rude, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 933 E Pierce St, Council Bluffs, IA 51503 Phone: 712-396-4360 Fax: 712-396-7069 | |
Shannon Ranae Stafford, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1604 2nd Ave, Council Bluffs, IA 51501 Phone: 712-322-6650 Fax: 712-328-7985 | |
Brian Luedke, RN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 933 E Pierce St, Council Bluffs, IA 51503 Phone: 712-396-4360 Fax: 712-396-7069 | |
Ms. Emily Wickham, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3434 W Broadway Ste 100, Council Bluffs, IA 51501 Phone: 712-325-0022 | |
Jessalyn Brockman, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1 Edmundson Pl Ste 200, Council Bluffs, IA 51503 Phone: 402-390-4111 Fax: 402-390-4115 |